These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12580931)

  • 1. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Mäkitie O; Kooh SW; Sochett E
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets.
    Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
    Alon US; Levy-Olomucki R; Moore WV; Stubbs J; Liu S; Quarles LD
    Clin J Am Soc Nephrol; 2008 May; 3(3):658-64. PubMed ID: 18256372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tertiary hyperparathyroidism during the treatment of familial hypophosphatemic rickets].
    Moreno Molina JA; López Siguero JP; Bueno Fernández A; Martínez-Aedo Ollero MJ; Martínez Valverde A
    An Esp Pediatr; 1996 Aug; 45(2):193-5. PubMed ID: 8967654
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension in hypophosphatemic rickets--role of secondary hyperparathyroidism.
    Alon US; Monzavi R; Lilien M; Rasoulpour M; Geffner ME; Yadin O
    Pediatr Nephrol; 2003 Feb; 18(2):155-8. PubMed ID: 12579406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets--application of the calcium infusion test as an indicator for parathyroidectomy.
    Alon U; Newsome H; Chan JC
    Int J Pediatr Nephrol; 1984 Mar; 5(1):39-43. PubMed ID: 6609135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Wu CJ; Song YM; Sheu WH
    Intern Med; 2000 Jun; 39(6):468-71. PubMed ID: 10852165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review.
    Yavropoulou MP; Kotsa K; Gotzamani Psarrakou A; Papazisi A; Tranga T; Ventis S; Yovos JG
    Hormones (Athens); 2010; 9(3):274-8. PubMed ID: 20688626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 12. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
    Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet.
    Raeder H; Shaw N; Netelenbos C; Bjerknes R
    Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S101-5. PubMed ID: 18775977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.
    Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK
    J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ectopic cardiac calcification associated with hyperparathyroidism in a boy with hypophosphatemic rickets.
    Moltz KC; Friedman AH; Nehgme RA; Kleinman CS; Carpenter TO
    Curr Opin Pediatr; 2001 Aug; 13(4):373-5. PubMed ID: 11717565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of hyperparathyroidism in children with X-linked hypophosphatemia under treatment with vitamin D and phsophate.
    Krohn HP; Offermann G; Brandis M; Brodehl J; Hanke K; Offner G
    Adv Exp Med Biol; 1977; 81():345-51. PubMed ID: 899930
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension is a characteristic complication of X-linked hypophosphatemia.
    Nakamura Y; Takagi M; Takeda R; Miyai K; Hasegawa Y
    Endocr J; 2017 Mar; 64(3):283-289. PubMed ID: 28025445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
    Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA
    Nephron; 1993; 64(4):526-31. PubMed ID: 8396209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.